Skip to content

Clinical trials

Phase 2 Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20072
20084
20093
20101
20122
20131
20142
20181
20192
20201
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kyowa Kirin Co., Ltd.3
Bayer2
Genzyme, a Sanofi Company2
Ineos Healthcare Limited2
Novartis Pharmaceuticals2
Alebund Pharmaceuticals1
Ardelyx1
Astellas Pharma Inc1
Duke University1
Ilypsa1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia27
Renal Insufficiency, Chronic10
Kidney Failure, Chronic6
Kidney Diseases3
Renal Insufficiency2
Bronchiolitis Obliterans Syndrome1
Hypophosphatemia1
Inflammation1
Pancreatitis1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.